Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of <i>Ginkgo biloba</i> extract, EGb 761^®

CNS Neuroscience & Therapeutics

The Expert Group foresee an important role for EGb 761^® , used alone or as an add-on therapy, in the treatment of MCI and dementias, particularly when patients do not derive benefit from acetylcholinesterase inhibitors or NMDA antagonists. EGb 761^® should be used in alignment with local clinical practice guidelines.

Authors: Nagaendran Kandiah, Paulus Anam Ong, Yuda Turana, Li‐Ling Ng, Kaysar Mamun, Reshma Aziz Merchant, Christopher Chen, Jacqueline C. Dominguez, S. Marasigan, Encarnita Ampil, Van Thong Nguyen, Suraya Yusoff, Yee Fai Chan, Fee Mann Yong, Orapitchaya Krairit, Chuthamanee Suthisisang, Vorapun Senanarong, Yong Ji, Ramesh Thukral, Ralf Ihl

DOI: https://doi.org/10.1111/cns.13095

Publish Year: 2019